Clinical trials
Phase 1/2 Fanconi Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 5 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bellicum Pharmaceuticals | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Sierra Oncology LLC - a GSK company | 2 |
| Agnieszka Czechowicz | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Baylor College of Medicine | 1 |
| Boston Children's Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Foresee Pharmaceuticals Co., Ltd. | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fanconi Anemia | 17 |
| Anemia, Aplastic | 3 |
| Anemia, Diamond-Blackfan | 3 |
| Leukemia | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Anemia | 2 |
| Anemia, Sickle Cell | 2 |
| Cytopenia | 2 |
| Hematologic Neoplasms | 2 |
| Hemoglobinopathies | 2 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.